M11.262 Other chondrocalcinosis, left knee

Name of the Condition

• Other chondrocalcinosis, left knee

Summary

Other chondrocalcinosis, left knee refers to the deposition of calcium-containing crystals in the left knee joint tissues, excluding calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite. This condition causes joint inflammation, pain, and potential structural damage, often mimicking other arthritic diseases. Diagnosis typically requires identifying the specific crystal type through joint fluid analysis or tissue sampling.

Causes

Other chondrocalcinosis, left knee is caused by the deposition of non-CPPD, non-hydroxyapatite calcium crystals (e.g., calcium oxalate, calcium phosphate) in the left knee’s cartilage, synovium, or surrounding tissues. The exact triggers vary but may include metabolic imbalances, genetic factors, or underlying systemic conditions. Crystal formation provokes an inflammatory response, leading to joint symptoms.

Risk Factors

• Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
• Chronic kidney disease or dialysis.
• Genetic predisposition to crystal formation.
• Exposure to certain medications or toxins.
• Knee trauma or surgery.

Symptoms

• Left knee pain, swelling, and stiffness.
• Warmth and redness over the affected joint.
• Reduced range of motion.
• Recurrent episodes of inflammation.
• Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves clinical evaluation of the left knee, imaging (e.g., X-ray, MRI) to assess crystal deposition or joint damage, and joint fluid analysis to identify the specific crystal type. Tissue sampling may be used if crystal identification is unclear.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
• Corticosteroid injections to reduce acute symptoms.
• Disease-modifying therapies targeting underlying metabolic causes, if applicable.
• Physical therapy to maintain joint function and mobility.
• Surgical intervention for severe joint damage or persistent symptoms.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of crystal deposition. Early diagnosis and management can reduce joint damage, but recurrent inflammation may occur. Regular follow-up with imaging and clinical assessments is recommended to monitor joint health and adjust treatment as needed.

Complications

• Progressive joint degeneration or osteoarthritis.
• Chronic pain and functional impairment.
• Recurrent acute inflammatory episodes.
• Systemic involvement in severe cases.

Lifestyle & Prevention

• Maintain a balanced diet to support metabolic health.
• Stay hydrated, especially if at risk for crystal formation.
• Avoid excessive joint stress or trauma.
• Manage underlying conditions (e.g., kidney disease) with medical guidance.
• Use protective measures during physical activity to reduce knee injury risk.

When to Seek Professional Help

Seek care if you experience persistent left knee pain, swelling, or stiffness that interferes with daily activities, or if symptoms worsen despite home care. Acute severe pain, redness, or fever requires prompt evaluation to rule out infection or other complications.

Tips for Medical Coders

Document the specific site (left knee) and confirm the exclusion of CPPD or hydroxyapatite crystals. Ensure clinical notes support the diagnosis and crystal type identification, as these details are critical for accurate coding. Verify that the code aligns with the documented location and crystal characteristics.